GlassScriptPhysician profile
Fredric M Radoff
NPI 1255419388
$1,402.84
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,094 · 2020: $309.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $309.86 | 2019 | |
| Supernus Pharmaceuticals, INC. | $160.87 | 2019-2020 | |
| Amgen INC. | $152.73 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $141.81 | 2019-2020 | |
| Genzyme Corporation | $139.33 | 2019 | |
| Novartis Pharmaceuticals Corporation | $82.53 | 2019-2020 | |
| Allergan, INC. | $72.94 | 2019-2020 | |
| Csl Behring | $56.49 | 2019-2020 | |
| Genentech USA, INC. | $45.82 | 2019 | |
| Abbvie INC. | $45.30 | 2019 | |
| Mdd US Operations, LLC | $40.68 | 2020 | |
| Eisai INC. | $39.42 | 2019-2020 | |
| Kyowa Kirin, INC. | $32.22 | 2020 | |
| Assertio Therapeutics, INC. | $30.13 | 2019 | |
| Lilly USA, LLC | $27.91 | 2019-2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adamas Pharmaceuticals, INC. | $24.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fredric Radoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.